For security practitioners, it could seem impossible to catch everything that happens in a wide, crowded space. Stadiums and other large, public venues require near-perfect surveillance systems to do so. New technology developed by the Department of Homeland Security Science and Technology Directorate (S&T) offers a novel 360-degree, single-vantage-point surveillance capability. https://www.dhs.gov/science-and-technology/news/2019/04/30/snapshot-st-immersive-imaging-system-winner-rd-100-award
The Defense Advanced Research Projects Agency’s (DARPA) SIGMA program, which began in 2014, has demonstrated a city-scale capability for detecting radiological and nuclear threats that is now being operationally deployed. DARPA is building off this work with the SIGMA+ initiative that is focused on providing city- to region-scale detection capabilities across the full chemical, biological, radiological, nuclear, and explosive threat space.
A team of scientists including researchers at the U.S. Department of Energy’s Brookhaven National Laboratory has studied a catalyst that decomposes nerve agents, eliminating their harmful and lethal effects. The research was published 19 April 2019, in the Journal of Physical Chemistry Letters.
Acting Secretary of Homeland Security Kevin K. McAleenan announced the establishment of the new Department of Homeland Security Office for Targeted Violence and Terrorism Prevention. The Office for Targeted Violence and Terrorism Prevention widens the scope of previous departmental efforts to ensure that all forms of violence, regardless of the ideological motivation, are being addressed.
The National Biodefense Science Board serves as a group of thought leaders who advise the U.S. Department of Health and Human Services (HHS) Secretary and the HHS Assistant Secretary for Preparedness and Response (ASPR) on issues related to biodefense, public health emergency preparedness, response and recovery, and other issues related to national health security. HHS ASPR is now soliciting applications for new board members. Applications will be accepted until 15 June 2019.
The Department of Homeland Security (DHS) announced the release of Fiscal Year (FY) 2019 Notices of Funding Opportunity for eight DHS preparedness grant programs totaling more than $1.7 billion. The grant programs provide funding to state, local, tribal, and territorial governments, as well as transportation authorities, nonprofit organizations, and the private sector, to improve the nation’s readiness in preventing, protecting against, responding to, recovering from, and mitigating terrorist attacks, major disasters, and other emergencies.
Part of the general mandate of the Bureau of International Security and Nonproliferation, is to stem – and, if possible, to roll back – the spread of weapons of mass destruction (WMD), delivery systems, and advanced conventional weapons. Dr. Christopher Ashley Ford, Assistant Secretary, Bureau of International Security and Nonproliferation, discusses the challenges of biosecurity.
The U.S. Fire Administration reported over 1.3 million structure fires in 2017 causing an estimated 3,400 deaths, 14,670 injuries and $23 billion dollars in damages. The high cost of today's fire problem in lives and property is leading some researchers to look for innovative fire protection solutions. One such solution is nanotechnology. It is used to make building and product materials stronger, lighter and at the same time, more fire resistant.
The Federal Bureau of Investigation (FBI) Victim Services Response Team (VSRT) is a specially trained cadre of FBI personnel whose primary function is to address the needs of victims in mass casualty events. The FBI’s VSRT, which includes victim specialists, agents, and analysts from around the country, was established in 2005 to provide support for victims in large-scale events.
Johnson & Johnson Innovation LLC and Children’s National Health System announced a collaboration to launch JLABS @ Washington, DC, a 32,000-square foot facility to be located at the new Children’s National Research and Innovation Campus in Washington, D.C. As part of the JLABS @ Washington, DC launch, the Biomedical Advanced Research and Development Authority will collaborate with Johnson & Johnson Innovation–JLABS to develop and maintain a specialized innovation zone dedicated to the advancement of medical countermeasures aimed at securing the nation from chemical, biological, radiological and nuclear threats, as well as from pandemic influenza and emerging infectious diseases.